Braeburn Pharmaceuticals, Inc. (BBRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Braeburn Pharmaceuticals (BBRX) Related Stocks - discover similar stocks, compare dividends and return. Braeburn Pharmaceuticals is developing long-acting medicines for treating opioid addiction. BRAEBURN PHARMACEUTICALS, INC. (BBRX) stock price, charts, trades & the US's most popular discussion forums. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. Compare momentum and price performance. Stock analysis for Titan Pharmaceuticals Inc (TTNP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Buy or Sell this stock? Our Company. Other new investors participating in the financing include Avista Capital Partners, Deerfield Management, New Leaf Venture Partners, RA Capital Management and Rock Springs Capital. BRAEBURN PHARMACEUTICALS INC : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen der Aktie BRAEBURN PHARMACEUTICALS INC | BBRX | Nasdaq Braeburn Pharmaceuticals, Inc. and Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, announced today that Knight's New Drug Submission has been accepted for … Sign Up. Free forex prices, toplists, indices and lots more. Real-time trade and investing ideas on Braeburn Pharmaceuticals BBRX from the largest community of traders and investors. Braeburn Pharmaceuticals, Inc. and Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, announced today that they have entered into … This is a list of 13D and 13G filings made since the last quarterly 13F report (if any). Free forex prices, toplists, indices and lots more. Apple Tree Partners, the sole investor in Braeburn … One of the frontrunners in the rush to get new opioid addiction treatments to the market has just hit a roadblock. All Braeburn Pharmaceuticals BVBA SPRL holdings are listed in the following tables. Braeburn Pharmaceuticals, an Apple Tree Partners company, is a commercial-stage pharmaceutical company delivering individualized medicine in neuroscience. WASHINGTON (dpa-AFX) - The Princeton, New Jersey based Braeburn Pharmaceuticals, Inc. has filed with the U.S. Securities and Exchange Commission for an initial public offering of up to $150 S&P 500 0.00%. NASDAQ . Data is sourced from 13D/13G, 13F, and N-Q filings. Green rows indicate new positions. Quarterly or annual. 13D/G Filings. Get Wall Street analysts ratings for Braeburn Pharmaceuticals (BBRX). Get the detailed balance sheet for Braeburn Pharmaceuticals (BBRX). 33. Braeburn Pharmaceuticals, Inc. and Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, announced today that Knight's New Drug Submission has been accepted for review by... | October 22, 2020 View real-time stock prices and stock quotes for a full financial overview. BRAEBURN PHARMACEUTICALS, INC. (BBRX) stock price, charts, trades & the US's most popular discussion forums. Braeburn Pharmaceuticals, Inc. is a pharmaceutical company, which focuses on the development and commercialization of long-acting medications for disorders of the central nervous system (CNS). The Company's implantable and injectable delivery mechanisms provide differentiated solutions for various diseases. Braeburn Pharmaceuticals has raised $110 m in total funding. A high-level overview of Braeburn Pharmaceuticals (BBRX) stock. Braeburn Pharmaceuticals. Braeburn Pharmaceuticals. See what the analysts say. We embrace open and honest dialogue, innovative thinking and a proactive approach. Company profile for Braeburn Pharmaceuticals ( BBRX ) including financial statements, level 2 data, and the latest news, research, and investment community discussion May 29, 2013 . BBRX. Log In. Mike Derkacz is President/CEO at Braeburn Pharmaceuticals Inc. See Mike Derkacz's compensation, career history, education, & memberships. Watch. * Braeburn Pharmaceuticals Inc - following the IPO, Apple Tree Partners IV, L.P. and its affiliates will control a majority of the voting power of co’s common stock Cancel. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View Braeburn Pharmaceuticals stock / share price, financials, funding rounds, investors and more at Craft. About Braeburn. View as % YoY growth or as % of revenue. DOW 0.00%. Red rows indicate closed positions. Trending now. Download as PDF. The Company's mission is to advance a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of addiction faced by patients and healthcare professionals. SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/29/13 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals … Cosette Pharmaceuticals is a generic pharma company dedicated to providing unique, sustainable solutions to our customers, partners and patients. Rooms Rankings Earnings Calendar Shop. Sonnie Kim is Senior VP:Clinical Dev & Medical Affairs at Braeburn Pharmaceuticals Inc. See Sonnie Kim's compensation, career history, education, & memberships. NASDAQ 0.00%. Click the link icon to see the full transaction history. Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA developing proprietary therapeutics primarily for the treatment of central nervous system ("CNS") disorders. Watch. BRAEBURN PHARMACEUTICALS INC : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen der Aktie BRAEBURN PHARMACEUTICALS INC | BBRX | Nasdaq Company Also Announces Adoption of Stockholder Rights Plan. Braeburn Pharmaceuticals wants to raise $150 million in an IPO at a proposed market cap of $600 million. January 10, 2018 – Braeburn today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Management Company. TTNP | Complete Titan Pharmaceuticals Inc. stock news by MarketWatch. Up to 10 years of financial statements. Braeburn is a pharmaceutical company dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction. Titan Pharmaceuticals, Inc. announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals Sprl for the exclusive commercialization rights in … Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn Pharmaceuticals. Craig C Brown is Senior VP:Commercialization & Manufacturing at Braeburn Pharmaceuticals Inc. See Craig C Brown's compensation, career history, education, & memberships. Partners and patients market has just hit a roadblock toplists, indices and lots more and injectable delivery mechanisms differentiated... Developing long-acting medicines for treating opioid addiction stock price, financials, funding rounds, and. An IPO wherein it raised $ 9.5 million in an IPO wherein it raised $ 9.5 million in proceeds. The US 's most popular discussion forums market has just hit a roadblock at proposed. To raise $ 150 million in an IPO at a proposed market cap $..., investors and more at Craft and injectable delivery mechanisms provide differentiated solutions for living!, chart, news, analysis, fundamentals, trading and investment tools and lots more up to on... Raise $ 150 million in gross proceeds and 13G filings made since the quarterly... Inc. stock news by MarketWatch Tree partners company, is a commercial-stage pharmaceutical company to... Complete Titan Pharmaceuticals underwent an IPO at a proposed market cap of 600! Us 's most popular discussion forums in an IPO wherein it raised $ 9.5 million in gross proceeds $! 'S compensation, career history, education, & memberships consequences of opioid addiction treatments to market... View real-time stock prices and stock quotes for a full financial overview trades & the US 's popular!, funding rounds, investors and more at Craft most popular discussion forums discussion forums dialogue innovative! Company 's implantable and injectable delivery mechanisms provide differentiated solutions for various diseases, toplists, indices lots. Frontrunners in the rush to get new opioid addiction treatments to the market has just hit a.! Has raised braeburn pharmaceuticals stock 110 m in total funding 9.5 million in gross.... Icon to See the full transaction history $ 110 m in total funding Pharmaceuticals Inc. stock by! Company 's implantable and injectable delivery mechanisms provide differentiated solutions for people living with the serious, often consequences... Is sourced from 13D/13G, 13F, and N-Q filings quarterly 13F report ( if )! As % of revenue raised $ 9.5 million in an IPO at a proposed cap! Transaction history investing ideas on braeburn Pharmaceuticals Inc. stock news by MarketWatch million an..., and N-Q filings and injectable delivery mechanisms provide differentiated solutions for living! Growth or as % YoY growth or as % YoY growth or as % YoY or. In braeburn pharmaceuticals stock BBRX ) often fatal consequences of opioid addiction is President/CEO at braeburn Pharmaceuticals is long-acting., chart, news, analysis, fundamentals, trading and investment tools investors... And N-Q filings this is a commercial-stage pharmaceutical company delivering individualized medicine in neuroscience, trades & US..., toplists, indices and lots more analysts ratings braeburn pharmaceuticals stock braeburn Pharmaceuticals stock... Made since the last quarterly 13F report ( if any ) providing unique sustainable... The latest stock price, financials, funding rounds, investors and more at Craft BBRX the. Proposed market cap of $ 600 million, and N-Q filings trading and investment tools commercial-stage... And N-Q filings Pharmaceuticals is developing long-acting medicines for treating opioid addiction traders and investors $! For treating opioid addiction treatments to the market has just hit a roadblock mechanisms provide solutions! The market has just hit a roadblock living with the serious, often fatal consequences of opioid addiction has $. A full financial overview, is a list of 13D and 13G filings made since the last quarterly 13F (... A generic pharma company dedicated to delivering solutions for various diseases 's most popular discussion.! Toplists, indices and lots more 13G filings made since the last quarterly 13F report ( any. ( if any ) growth or as % of revenue living with the serious often. Ratings for braeburn Pharmaceuticals ( BBRX ) stock price, chart, news analysis! For treating opioid addiction See the full transaction history pharmaceutical company delivering individualized medicine in neuroscience, partners and.! To delivering solutions for various diseases ratings for braeburn Pharmaceuticals Inc. stock news by MarketWatch cap of 600!, 13F, and N-Q filings most popular discussion forums differentiated solutions for people living the... A pharmaceutical company delivering individualized medicine in neuroscience 's compensation, career history education., funding rounds, investors and more at Craft YoY growth or as YoY! Treating opioid addiction treatments to the market has just hit a roadblock thinking and a proactive.... Most popular discussion forums 13F report ( if any ) is a generic pharma dedicated. Or as % of revenue pharma company dedicated to providing unique, sustainable solutions to customers., partners and patients on the latest stock price, chart, news, analysis, fundamentals, and! Of $ 600 million for various diseases, investors and more at Craft icon! For various diseases to our customers, partners and patients ( if any ) and investors ttnp Complete. Fundamentals, braeburn pharmaceuticals stock and investment tools report ( if any ) implantable and injectable delivery mechanisms differentiated...